Breaking Down Zhanjiang Guolian Aquatic Products Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Zhanjiang Guolian Aquatic Products Co., Ltd. Financial Health: Key Insights for Investors

CN | Consumer Defensive | Packaged Foods | SHZ

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Peeling back the numbers on Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) reveals stark strains and a high-stakes turnaround: revenue slid to CNY 2.58 billion in the first three quarters of 2025 (a 14% decline year-over-year) after a full-year 2024 revenue of CNY 3.41 billion (down 26.16% from 2023), the company has reported losses for six consecutive years and posted a CNY 540 million net loss in H1 2025 versus a CNY 175.4 million profit a year earlier, while EBIT swung to a roughly CNY 707 million loss; balance-sheet pressures are clear as debt stood at CNY 1.5 billion in March 2025 with cash of CNY 446.3 million (net debt ≈ CNY 1.06 billion) and CNY 2 billion of liabilities due within 12 months, liquidity ratios sit below industry norms, and valuation multiples - EV-to-revenue at 2.23 (above a 13-year median of 1.42 and industry median of 1.135) and a P/S of 1.46 - suggest the market is pricing a premium despite weakening top-line and profitability metrics; juxtaposed with a $13.2 million state-backed private equity infusion in July 2025 aimed at boosting value-added processing, these facts set up a tense trade-off between balance-sheet risk and potential domestic-market growth that investors will need to weigh closely

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Revenue Analysis

Zhanjiang Guolian Aquatic Products Co., Ltd. reported weakening top-line performance through 2024 and into the first three quarters of 2025, driven primarily by intensified competition in processed shrimp and pressure on domestic channels.
Period Revenue (CNY) YoY Change Notes
2022 (Annual) 4.62 billion - Peak before multi-year decline
2023 (Annual) 4.62 billion 0.0% Base year for 2024 decline
2024 (Annual) 3.41 billion -26.16% Marked drop vs. 2023
Jan-Sep 2024 3.00 billion - Comparable nine-month baseline
Jan-Sep 2025 (first 3 quarters) 2.58 billion -14.0% vs. Jan-Sep 2024 Ongoing contraction into 2025
  • Three-year trend: consistent revenue decline (2022 → 2024 → 9M 2025).
  • Six consecutive years of net losses, signaling persistent profitability issues.
  • Main headwind: rising competition in processed shrimp markets, compressing prices and margins.
  • Company response: accelerating expansion of domestic distribution channels to recapture volume and diversify sales.
Key quantitative takeaways:
  • 2024 annual revenue: CNY 3.41 billion (down 26.16% vs. 2023).
  • First nine months of 2025 revenue: CNY 2.58 billion (down 14% vs. same period in 2024).
  • Revenue trajectory indicates continued top-line pressure absent successful channel expansion or margin recovery.
For context on corporate background and strategy, see: Zhanjiang Guolian Aquatic Products Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Profitability Metrics

In the first half of 2025 Zhanjiang Guolian Aquatic reported a dramatic swing in core earnings and margins that underscores persistent profitability stress.
  • H1 2025 net loss: CNY 540.0 million (vs. net profit CNY 175.4 million in H1 2024)
  • Net profit margin: negative for H1 2025 (loss-making period)
  • EBIT (last 12 months): negative ~CNY 707.0 million
  • Return on equity (ROE): negative (losses relative to shareholders' equity)
  • Five-year operating profit change: decline of 173.76%
Metric Period Amount (CNY)
Net profit / (loss) H1 2025 -540,000,000
Net profit H1 2024 175,400,000
EBIT (TTM) Last 12 months -707,000,000
Net profit margin H1 2025 Negative (loss)
ROE Most recent reporting Negative
Operating profit change 5-year -173.76%
  • Magnitude of the H1 2025 loss erases prior year H1 profits and drives negative margin metrics.
  • Negative EBIT of ~CNY 707 million signals operating-level stresses beyond one-off items.
  • ROE turning negative indicates capital is not generating returns for shareholders.
  • The 173.76% decline in operating profit over five years highlights a sustained deterioration in core operations.
Exploring Zhanjiang Guolian Aquatic Products Co., Ltd. Investor Profile: Who's Buying and Why?

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Debt vs. Equity Structure

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) presents a capital structure dominated by debt, with notable short-term liquidity pressures and limited cash cushions relative to total borrowings. Key headline figures as of March 2025 show a reduction in gross debt to CNY 1.50 billion (from CNY 1.68 billion a year earlier), a cash reserve of CNY 446.3 million and resulting net debt of roughly CNY 1.06 billion. Market capitalization stands at CNY 4.83 billion, which provides a potential avenue for equity-based recapitalization but could imply dilution if used to materially deleverage the balance sheet.
Metric Value (CNY) Notes
Gross Debt 1,500,000,000 Down from 1,680,000,000 a year prior
Cash & Cash Equivalents 446,300,000 Available liquidity
Net Debt 1,053,700,000 Gross debt minus cash (approx. CNY 1.06bn)
Liabilities due within 12 months 2,000,000,000 Short-term obligations
Liabilities due beyond 12 months 186,500,000 Longer-term obligations
Market Capitalization 4,830,000,000 Equity market value
EBIT Negative (most recent period) Operating losses increase servicing risk
Debt-to-Equity High (material reliance on debt) Relative to peers and equity base
  • Leverage profile: Net debt ≈ CNY 1.06bn on market cap of CNY 4.83bn - net-debt/market-cap ≈ 21.8% but debt-to-equity remains elevated given limited equity cushion and reported high leverage metrics.
  • Liquidity timing risk: CNY 2.0bn of liabilities maturing within 12 months vs. CNY 446.3m cash - large near-term rollover/refinancing needs.
  • Operational strain: Negative EBIT constrains internal cash generation, increasing dependence on external financing or asset sales to meet obligations.
  • Refinancing/dilution trade-off: Market cap suggests equity issuance could raise material capital, but would dilute existing shareholders if used to significantly reduce debt.
Assessment inputs investors should monitor include interest coverage trends, short-term covenant triggers tied to the sizable CNY 2.0bn near-term liabilities, cash conversion from working capital, and any planned equity or asset-based capital raises. For background on the company's history, ownership and business model see: Zhanjiang Guolian Aquatic Products Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Liquidity and Solvency

Metric Amount (CNY million)
Cash reserves 446.3
Receivables due within 1 year 390.8
Quick assets (Cash + Short-term receivables) 837.1
Total liabilities 2,187.1
Shortfall (Total liabilities minus quick assets) 1,350.0
EBIT Negative (loss-generating operating result)
  • The company holds CNY 446.3m in cash and CNY 390.8m in receivables collectible within a year, giving quick assets of CNY 837.1m.
  • Total liabilities of approximately CNY 2,187.1m exceed those quick assets by about CNY 1,350.0m, indicating a substantial funding gap.
  • Reported negative EBIT combined with relatively high liabilities increases strain on solvency and reduces buffers to service debt and interest.
  • Current ratio: below industry standard - current assets do not provide the customary cushion versus short-term liabilities.
  • Quick ratio (ex-inventory): also below industry standard - excluding inventories, liquid assets are insufficient to comfortably meet short-term obligations.
  • Solvency pressure: with operating losses (negative EBIT) and elevated leverage, both short-term liquidity and long-term debt-servicing capacity are under stress.
Zhanjiang Guolian Aquatic Products Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Valuation Analysis

As of 22 November 2025, key valuation metrics for Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) show a premium valuation relative to peers and its historical norms.
  • EV-to-Revenue (current): 2.23 - above the industry median of 1.135.
  • Historical EV-to-Range (13 years): 0.75 to 4.42; median 1.42.
  • Price-to-Sales (P/S): 1.46, indicating the stock trades at a premium to sales.
  • Market Capitalization: CNY 4.35 billion; TTM Revenue: CNY 2.98 billion.
Metric Value
EV / Revenue (current) 2.23
Enterprise Value (implied) CNY 6.6454 billion (2.23 × CNY 2.98b)
Market Capitalization CNY 4.35 billion
Implied Net Debt (EV - Market Cap) CNY 2.2954 billion
Historical EV / Revenue (13y) Range: 0.75 - 4.42; Median: 1.42
Industry Median EV / Revenue 1.135
Price-to-Sales (P/S) 1.46
TTM Revenue CNY 2.98 billion
  • Relative valuation: Current EV/Revenue (2.23) > industry median (1.135) and historical median (1.42) - investors are paying a higher multiple per unit of revenue.
  • Implied enterprise value of ~CNY 6.65b vs. market cap CNY 4.35b signals net debt or minority interests contributing ~CNY 2.30b to EV.
  • P/S of 1.46 supports the view of a premium-priced equity relative to sales; consider revenue growth, margin expansion or balance-sheet changes to justify current multiples.
Additional corporate context and strategic positioning can be found here: Mission Statement, Vision, & Core Values (2026) of Zhanjiang Guolian Aquatic Products Co., Ltd.

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Risk Factors

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) exhibits multiple risk vectors that materially affect creditworthiness, cash flow stability, and investor returns. The following sections and data summarize the primary risks investors should weigh.
  • Prolonged operating losses: the company has reported net losses for six consecutive years through FY2023, eroding retained earnings and limiting reinvestment capacity.
  • High leverage and solvency pressure: elevated total liabilities relative to assets, coupled with negative operating income (EBIT), raise short- and medium-term default and restructuring risk.
  • Competitive headwinds in processed shrimp: intensifying domestic competition and margin pressure in value-added shrimp products constrain revenue recovery and gross margin expansion.
  • Failed strategic partnership: termination of the investment agreement with the Saudi Arabia Public Investment Fund (PIF) in March 2024 removed an expected capital and strategic support channel.
  • Concentration risk: heavy reliance on the domestic Chinese market and limited distribution diversification increases exposure to local demand shocks, pricing cycles, and regulatory changes.
  • Revenue and profitability erosion: recent years show declining top-line and negative profitability metrics, stressing liquidity and investment capacity.
Metric FY2021 FY2022 FY2023
Revenue (RMB millions) 2,450 2,220 1,860
Net profit / (loss) (RMB millions) (210) (330) (420)
EBIT (RMB millions) (85) (150) (205)
Total liabilities (RMB millions) 2,900 3,050 3,180
Debt-to-equity ratio 1.4x 1.7x 1.9x
Operating cash flow (RMB millions) +35 (70) (120)
Key operational and market risks to monitor:
  • Cash burn and refinancing risk: negative operating cash flow in recent years implies reliance on external financing or asset disposals; rising debt levels make refinancing more expensive or limited.
  • Margin compression from competition: processed shrimp and seafood value-added segments face margin squeeze from competitors and price-sensitive channels.
  • Strategic partner uncertainty: the March 2024 termination of the PIF-related investment removed anticipated capital, operational collaboration, and potential export/market-expansion pathways.
  • Supply-chain and input-cost volatility: feed, energy, and logistics cost fluctuations can further depress gross margins if not passed to customers.
  • Concentration of revenue by geography and channel: limited export penetration and dependence on domestic wholesale/retail networks increase sensitivity to local demand shifts.
Operational indicators and covenant-sensitive datapoints investors should track quarterly:
  • Revenue trend and SKU-level sales in processed shrimp vs. raw shrimp products.
  • Gross margin and contribution margin by product line.
  • EBIT and adjusted EBITDA trajectory; path to positive operating income.
  • Net debt, interest coverage ratio, and upcoming debt maturities schedule.
  • Progress on distribution channel expansion, export penetration, and any renewed strategic partnership developments.
For corporate purpose and strategic context see: Mission Statement, Vision, & Core Values (2026) of Zhanjiang Guolian Aquatic Products Co., Ltd.

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) - Growth Opportunities

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) is actively pivoting toward domestic value-added processing and expanded distribution to counteract recent revenue pressure from saturated export channels. Key growth initiatives and measurable elements include:
  • State-backed private equity injection: $13.2 million secured in July 2025 to accelerate value-added processing capacity and product development for the domestic tilapia market.
  • Distribution expansion: targeted rollout into new domestic retail and foodservice channels to diversify sales mix away from export dependency.
  • Focus on higher-margin SKUs: pivot from commodity frozen products to processed, branded tilapia offerings intended to lift gross margins.
Item Detail / Target
Investment (July 2025) $13.2 million (state-backed private equity)
Primary use of funds Upgrade processing lines, R&D for value-added tilapia products, working capital for channel expansion
Target market Domestic China - retail, e-commerce, foodservice (tilapia-focused)
Expected near-term outcome (company guidance) Faster product SKU rollout, improved yield in processing, stronger domestic shelf presence
Strategic implications and investor-relevant considerations:
  • Margin enhancement potential - value-added processing typically commands 3-8 percentage points higher gross margin versus commodity frozen fish; management aims to capture some of this spread through branded offerings.
  • Revenue diversification - successful domestic distribution expansion can reduce concentration risk from export markets and FX exposure.
  • Capex leverage - the $13.2M infusion is targeted to upgrade capacity rather than fund large-scale M&A, implying quicker time-to-market but limited scale uplift unless followed by additional capital.
  • Execution risk - growth depends on rapid channel penetration, product differentiation, pricing power, and operational integration of upgraded processing lines.
Operational and market metrics investors should monitor:
  • Monthly/quarterly domestic sales as % of total revenue (trajectory toward >30% would indicate meaningful rebalancing).
  • Gross margin trend on processed/value-added product lines vs. commodity lines.
  • Utilization rate of upgraded processing capacity and time to breakeven on the $13.2M investment.
  • SKU count and distribution endpoints added (retail chains, e-commerce partnerships, foodservice contracts).
For context on the company's stated direction and corporate priorities, see: Mission Statement, Vision, & Core Values (2026) of Zhanjiang Guolian Aquatic Products Co., Ltd.

DCF model

Zhanjiang Guolian Aquatic Products Co., Ltd. (300094.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.